These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 5789897)

  • 1. Studies on cirramycin A1. IV. Derivatives of cirramycin A1.
    Tsukiura H; Konishi M; Saka M; Fujisawa K; Ohmori T
    J Antibiot (Tokyo); 1969 Mar; 22(3):100-5. PubMed ID: 5789897
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on cirramycin A1. II. Biological activity of cirramycin A1.
    Fujisawa K; Matsumoto K; Omori T; Hoshiya T; Kawaguchi H
    J Antibiot (Tokyo); 1969 Feb; 22(2):65-70. PubMed ID: 5770858
    [No Abstract]   [Full Text] [Related]  

  • 3. Biological activity of megalomicin A phosphate, a water-soluble salt of megalomicin A.
    Waitz JA; Moss EL; Oden EM; Weinstein MJ
    J Antibiot (Tokyo); 1971 May; 24(5):310-6. PubMed ID: 4996819
    [No Abstract]   [Full Text] [Related]  

  • 4. Activity and toxicity of bleomycin.
    Ishizuka M; Takayama H; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1967 Jan; 20(1):15-24. PubMed ID: 6072277
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on cirramycin A1. 3. Structure of cirramycin A1.
    Tsukiura H; Konishi M; Saka M; Naito T; Kawaguchi H
    J Antibiot (Tokyo); 1969 Mar; 22(3):89-99. PubMed ID: 5789903
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies on cirramycin A1. I. Isolation and characterization of cirramycin A1.
    Koshiyama H; Tsukiura H; Fujisawa K; Konishi M; Hatori M
    J Antibiot (Tokyo); 1969 Feb; 22(2):61-4. PubMed ID: 5770857
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pharmacological study on kasugamycin].
    Matsuzaki A; Yoshida A; Onodera K; Sekino M; Tado N; Asano M
    Jpn J Antibiot; 1968 Aug; 21(4):206-20. PubMed ID: 5304357
    [No Abstract]   [Full Text] [Related]  

  • 8. New cirramycin-family antibiotics F-1 and F-2. Selection of producer mutants, fermentation, isolation, structural elucidation and antibacterial activity.
    Sawada Y; Tsuno T; Miyaki T; Naito T; Oki T
    J Antibiot (Tokyo); 1989 Feb; 42(2):242-53. PubMed ID: 2925516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical study of polypeptide antibiotics, with special reference to absorption and excretion of enramycin].
    Kondo S
    Jpn J Antibiot; 1971 Dec; 24(6):272-6. PubMed ID: 5316824
    [No Abstract]   [Full Text] [Related]  

  • 10. Enduracidin, a new antibiotic. IV. The fate of enduracidin administered parenterally into rabbits.
    Tanayama S; Fugono T; Yamazaki T
    J Antibiot (Tokyo); 1968 May; 21(5):313-9. PubMed ID: 5726287
    [No Abstract]   [Full Text] [Related]  

  • 11. Bicyclomycin, a new antibiotic. IV. Absorption, excretion and tissue distribution.
    Nishida M; Mine Y; Matsubara T; Goto S; Kuwahara S
    J Antibiot (Tokyo); 1972 Oct; 25(10):594-601. PubMed ID: 4648313
    [No Abstract]   [Full Text] [Related]  

  • 12. Antibiotic 6640. 3. Biological studies with antibiotic 6640, a new broad-spectrum aminoglycoside antibiotic.
    Waitz JA; Moss EL; Oden EM; Weinstein MJ
    J Antibiot (Tokyo); 1970 Nov; 23(11):559-65. PubMed ID: 4992170
    [No Abstract]   [Full Text] [Related]  

  • 13. A new antibiotic, josamycin. II. Biological studies.
    Nitta K; Yano K; Miyamoto F; Hasegawa Y; Sato T
    J Antibiot (Tokyo); 1967 Jul; 20(3):181-7. PubMed ID: 6072799
    [No Abstract]   [Full Text] [Related]  

  • 14. Biological properties of macarbomycin, an antibiotic containing phosphorus.
    Takahashi S; Nitta K; Honjo S; Cho F; Umezawa H
    J Antibiot (Tokyo); 1973 Sep; 26(9):513-20. PubMed ID: 4209529
    [No Abstract]   [Full Text] [Related]  

  • 15. Biological activity of megalomicin, a new Micromonospora-produced macrolide antibiotic complex.
    Waitz JA; Moss EL; Oden EM; Weinstein MJ
    J Antibiot (Tokyo); 1969 Jun; 22(6):265-72. PubMed ID: 4390258
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies on new antibiotic lividomycins. VI. Absorption, excretion and tissue distribution of lividomycin A.
    Mori T; Aoki M; Aoki Y; Shirai K; Chiba K
    J Antibiot (Tokyo); 1972 Nov; 25(11):634-40. PubMed ID: 4647833
    [No Abstract]   [Full Text] [Related]  

  • 17. Local and systemic tolerance, absorption and excretion of clindamycin hydrochloride after intramuscular administration.
    Novak E; Wagner JG; Lamb DJ
    Int Z Klin Pharmakol Ther Toxikol; 1970 Jul; 3(3):201-8. PubMed ID: 4916038
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative pharmacokinetics of tobramycin and gentamicin.
    Regamey C; Gordon RC; Kirby WM
    Clin Pharmacol Ther; 1973; 14(3):396-403. PubMed ID: 4698568
    [No Abstract]   [Full Text] [Related]  

  • 19. Coumermycin A1-Biopharmaceutical studies. II.
    Newmark HL; Berger J; Carstensen JT
    J Pharm Sci; 1970 Sep; 59(9):1249-51. PubMed ID: 5469784
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical pharmacology of tobramycin.
    Horikoshi N; Valdivieso M; Bodey GP
    Am J Med Sci; 1973 Dec; 266(6):453-8. PubMed ID: 4774079
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.